Brain/ Mental Health
Time for a universal “exercise prescription” for kids and adults to boost cognition and mental health?
Welcome to a new edition of SharpBrains e‑newsletter, featuring this time a range of brain research findings, tools and controversies plus some brain teasers to challenge your (and our) working memory. #1. Major evidence review supports an “exercise prescription” for most adults to boost mental health “Higher intensity physical activity was associated with greater improvements”…
Read MoreEvidence review: Physical exercise helps boost attention, cognitive flexibility and inhibitory control in children and adolescents with ADHD
The impact of physical exercise on ADHD has been examined in a large number of studies. Collectively, these studies have examined whether exercise reduces on core ADHD symptoms, e.g., inattention and hyperactivity/impulsivity, and strengthens executive functions, e.g., inhibitory control, working memory, and mental health, e.g., emotional and social functioning. Overall, results across multiple studies suggest…
Read MoreHopes and Questions raised by Alzheimer’s drug Leqembi (lecanemab)
The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment. Medicare has said it will pay for the therapy. Medical centers across the country are scrambling to finalize policies and procedures for providing the medication to patients, possibly by summer’s end or early autumn. It’s a…
Read MoreNeurotech, neuroethics and brain data in context: Are “neurorights” the way to mental privacy?
Neurotechnologies – devices that interact directly with the brain or nervous system – were once dismissed as the stuff of science fiction. Not anymore. Several companies are trying to develop brain-computer interfaces, or BCIs, in hopes of helping patients with severe paralysis or other neurological disorders. Entrepreneur Elon Musk’s company Neuralink, for example, recently received…
Read MorePrice tag for a questionable Alzheimer’s treatment: $109,000 per patient, per year. Unclear yet: For how many years?
The real costs of the new Alzheimer’s drug, Leqembi — and why taxpayers will foot much of the bill (CBS News): The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors…
Read MoreJust-published Apple patent signals aim to measure brain activity using AirPods sensor system
Apple Invents a next-generation AirPods Sensor System that could measure Biosignals and Electrical Activity of a User’s brain (Patently Apple): Today the US Patent & Trademark Office published a patent application from Apple that relates to a next-generation of AirPods Sensor System wherein the housing and tips of AirPods could include a number of active and…
Read More